During the government shutdown, public health experts talked political and monetary hurdles, and fostering community amid ...
Gilead Sciences, Inc.’s GILD posted 3% year-over-year growth in total revenues for the third quarter of 2025.Total revenues comprise product sales and royalty, contract and other revenues.While higher ...
A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...